GENEVA, July 9 -- SHANGHAI ARGO BIOPHARMACEUTICAL CO., LTD. filed a patent application (CN2025/146432) for “COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF COMPLEMENT FACTOR B (CFB)”. With publication no. WO/2026/145382, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12N 15/113
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....